chrX-47142438-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM4BS2
The ENST00000276062.9(NDUFB11):c.334T>G(p.Ter112GlyextTer12) variant causes a stop lost, splice region change. The variant allele was found at a frequency of 0.00000661 in 1,209,829 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000276062.9 stop_lost, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NDUFB11 | NM_001135998.3 | c.341T>G | p.Met114Arg | missense_variant, splice_region_variant | 3/3 | ENST00000377811.4 | |
NDUFB11 | NM_019056.7 | c.371T>G | p.Met124Arg | missense_variant, splice_region_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NDUFB11 | ENST00000377811.4 | c.341T>G | p.Met114Arg | missense_variant, splice_region_variant | 3/3 | 1 | NM_001135998.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111760Hom.: 0 Cov.: 23 AF XY: 0.0000589 AC XY: 2AN XY: 33948
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 182987Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67451
GnomAD4 exome AF: 0.00000546 AC: 6AN: 1098069Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 4AN XY: 363429
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111760Hom.: 0 Cov.: 23 AF XY: 0.0000589 AC XY: 2AN XY: 33948
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2023 | The c.371T>G (p.M124R) alteration is located in exon 3 (coding exon 3) of the NDUFB11 gene. This alteration results from a T to G substitution at nucleotide position 371, causing the methionine (M) at amino acid position 124 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 16, 2023 | This sequence change replaces methionine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 124 of the NDUFB11 protein (p.Met124Arg). This variant is present in population databases (rs782673413, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with NDUFB11-related conditions. ClinVar contains an entry for this variant (Variation ID: 2511547). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at